Abercrombie & Fitch: Sharp Rallies Should Be Sold
Summary: Abercrombie & Fitch released its Q2 results last week, reporting quarterly revenue of $805.1
Summary: Abercrombie & Fitch released its Q2 results last week, reporting quarterly revenue of $805.1
Summary: Once a proud pipeline in a molecule, NUPLAZID (pimavanserin) rests on its old standby
Summary: Banks typically do not make it to the Dogs of the Dow list. However,
Summary: This is a technical analysis article. Here is our daily report on stocks reporting
Summary: NBCUni’s CEO Jeff Shell discusses Peacock/movie outlook. Currently, Peacock has 15 million paid subscribers
Summary: The current bear market presents great buying opportunities with low valuations and high dividend
Summary: American Tower is very well positioned to benefit from the growth in data usage
Summary: UNH posted another great earnings report for Q3. However, the bulls look tired. UNH
Summary: Get ahead of the market by subscribing to Seeking Alpha’s Stocks to Watch, a
Summary: COVID-19 vaccine Comirnaty and Paxlovid pill should contribute circa 55% to Pfizer’s 2022 revenues.